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ABSTRACT
Huge progress has been made in the development of three dimensionally printed
tissue structures. With the use of cells, three dimensional printers, and CAD drawing
software, donor identical structures can be fabricated. However, cell scaffolds currently
lack significant mechanical integrity which can result in reduced cellular survival,
attachment, and nutrient delivery. For this reason, multiple strategies have been developed
to increase and improve mechanical stability within engineered constructs without having
to sacrifice cell viability.
The hypothesis of this paper was that incorporating Perfluorotributylamine
(PFTBA), a greenhouse gas, with single walled carbon nanotubes (SWCNT), a allotrope
of carbon with a cylindrical nanostructure, into an alginate scaffold will not only increase
mechanical integrity but also cell survival. The following objectives were proposed: 1.
Fabricate and characterize cell laden scaffolds of alginate and 2. Assess the addition of
perfluorotributylamine and various concentrations of carbon nanotubes inside of cell laden
scaffolds of alginate. Three configurations of perfluorotributylamine and carbon
nanotubes were explored in an effort to maximize mechanical properties and
cytocompatibility. Perfluorotributylamine was combined with gelatin from bovine skin
and phosphate buffered solution to form a PFTBA emulsion. This emulsion was added to
each alginate scaffold to encompass 5% of the entire alginate scaffold. Single walled
carbon nanotubes were added in increasing concentrations to have four scaffolds, one
control, 0 µg/ml, .1 µg/ml, and 1 µg/ml. The results of this study indicate that the
configuration of 5% PFTBA emulsion + 1 µg/ml SWCNT + alginate, provided the best
cell viability results; Picogreen fluorescence of 8532, excellent viability in live/dead stain,
and sufficient morphological features while the control scaffold, containing alginate only,
provided the best mechanical properties after a 7 day period. The results contradict the
hypothesis that mechanical properties will increase with increasing SWCNT
concentration, but support the hypothesis of improved cell viability with the incorporation
of PFTBA emulsion to increasing SWCNT concentration.
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1. INTRODUCTION
1.1

Overview of Thesis
The first chapter introduces the history of three dimensional printing and its
modification to the process of bioprinting living cells. It mentions research into currently
used engineered scaffolds and its application in organ transplantation surgeries. Chapter 2
reviews recent literature for the currently used hydrogels with their advantages and
disadvantages, the chosen hydrogel used in this research, the additives used with the
intention of increasing cell viability and mechanical properties. Chapter 3 details the in
vitro three dimensional print fabrications and analysis of the various scaffold
configurations. Chapter 4 concludes this thesis and provides direction for future research
to better the development of engineered scaffolds.
1.2

History of Three Dimensional Printing
The idea of mass replication and production has been around for many centuries.
With recent advancements in technology over the last couple of years, additive
manufacturing has transformed from the production of two dimensional shapes into that
of three dimensional. Rapid production of three dimensional shapes helped to increase
the production speed of various products such as jewelry, electronics, and plastics in
various industries such as automotive, aviation, and manufacturing. [1] In 1986, Charles
W. Hull first depicted three dimensional (3D) printing as a method, deemed
stereolithography, where thin layers of material were consecutively printed to form a
solid three dimensional structure that was cured with ultraviolet light. [2] This process
was later modified to create sacrificial resin molds that would form three dimensional
scaffolds from biological materials. [1]
1.3 Three Dimensional Bioprinting
Bioprinting is a computer-aided manufacturing technique that allows the
construction of structures layer by layer using biological materials, biochemicals, and
living cells, with spatial control of functional components. [1] A bioprinter is constituted
of a computer-aided positioning and deposition system, a bioink that feeds the deposition
system, and a biopaper that acts as the substrate for the deposition. The computer controls
the placing apparatus by moving the sample or the deposition heads along a
predetermined path, initiating the deposition of the bioink when needed. Bioprinting is
based on three approaches which include; biomimicry, autonomous self-assembly, and
mini tissue building blocks. [1] Biomimicry involves the manufacturing of identical
reproductions of the cellular and extracellular components of a tissue or organ. [3] In
order to achieve biomimicry, distinct cellular functional components must be duplicated
on a microscale. An understanding of the microenvironment, including the specific
arrangement of functional and supporting cell types, gradients of soluble and insoluble
factors, and composition of the extracellular matrix (ECM) is needed. [1] Autonomous
self-assembly uses embryonic organ development as a guide. This approach relies on the
cell as the primary driver of histogenesis, directing the composition, localization,
functional, and structural properties of the tissue. [4, 5] The last approach, mini tissues
can be fabricated and assembled into larger tissues by driven design, self-assembly, or a
1

combination. There are two strategies within mini tissues, self- assembling cell spheres
which are assembled into large tissue and accurate, high-resolution reproductions of a
tissue unit which are designed and then allowed to self-assemble into larger tissue.
[6,7,8,9] Fabrication of these 3D biological structures are manufactured using various
types of micro-extrusion printers, computer aided design software, and mathematical
modeling to collect and digitize the complex tomographic and architectural design of the
proposed tissue structure. Current bioprinting technologies are divided into three types of
printers, which are, inkjet, microextrusion, and laser-assisted.
1.3.1 Microextrusion Bioprinter
Microextrusion bioprinters are the most common and affordable of the three
types. These printers are more commonly used in personal and academic institutions with
higher quality industrial versions that offer better resolution, speed, and spatial control.
[10] Microextrusion bioprinters have been used to fabricate various tissue types, such as,
aortic valves, branched vascular trees, as well as tumor models [1]. Material is deposited
in continuous beads of material rather than liquid droplets. The three types of
microextrusion bioprinters are pneumatic, piston, and screw dispensing systems, the last
two of which are deemed mechanical. [11, 12, 13] Pneumatic dispensers are
advantageous due to simpler drive-mechanism components, with the force limited only
by the air-pressure capabilities of the system, suited to dispense high-viscosity materials.
One disadvantage includes less control of flow due to the delay of the compressed gas
volume. Mechanical dispensing systems have smaller and more complex components
which offer more spatial control over the material flow, and are thought to be beneficial
for the dispensing of hydrogels with higher viscosities. [14] These benefits often result in
reduced maximum force capabilities.
The main advantage of microextrusion bioprinting technology is the ability to
deposit very high cell densities. Achieving physiological cell densities in tissueengineered organs is a major goal for the bioprinting field. Cell viability after
microextrusion bioprinting is in the range of 40–86%, depending on extrusion pressure
and nozzle gauge. [15,16] Use of improved biocompatible materials, such as hydrogels,
that are mechanically robust during printing and that develop secondary mechanical
properties after printing can improve cell viability and function after the printing process.
[17, 18]
1.4

Engineered Scaffolds
Tissue engineering aspires to devise ways to artificially produce organs and tissue
structures in the human body. In 3D printing, layer by layer precise positioning of
biological materials, biochemical and living cells, with spatial control of the placement of
functional components, are used to fabricate 3D structures in the form of scaffolds. [1]
The field of bioprinting also faces other challenges shared by all researchers in the fields
of tissue engineering and regenerative medicine. The central challenge is to reproduce the
complex micro-architecture of extracellular matrix (ECM) components and multiple cell
types in sufficient resolution to repeat biological function. [1] Another challenge in the
3D bioprinting field has been to find materials that are not only compatible with
biological materials and the printing process but can also provide the desired mechanical
and functional properties for tissue constructs.
2

1.5

Description of the Need for Engineered Scaffolds
The most popular treatment for loss or damaged tissues and organs is organ
transplantation. According to the U.S. Department of Health and Human Services
(DHH), an average of 21 patient deaths occur each day waiting for transplants that cannot
take place due to the shortage of donated organs. [19] Thus there is a significant need for
improved techniques to combat the reproduction and repair of various organs as they fail
or become obsolete. The concept of complete organ reproduction is in infancy however;
the research surrounding producing a patient’s own cells in the form of hydrogel scaffold
is a stepping stone to reach this goal.
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2. LITERATURE REVIEW
2.1

Hydrogels for Tissue Engineering
Drury et al. provides a thorough review of the various hydrogels used for tissue
engineering applications. There are various strategies used to engineer tissues that depend
on incorporating a material scaffold. These scaffolds are used to mimic the extracellular
matrix so that cells can be distributed into a three-dimensional architecture to properly
grow and form the intended tissue. [20] In order to produce these scaffolds, a class of
highly hydrated polymer materials with water content greater than 30% by weight
deemed hydrogels, are being used. These hydrogels are made up of natural and synthetic
hydrophilic polymer chains which have similar characteristics to tissues and ECM. [21]
Selection between these two types of hydrogels is dependent upon several factors such as
rate of gel formation, nutrient diffusion, and cell adhesion.
2.1.1 Synthetic hydrogels
The use of synthetic hydrogels in tissue engineering is due to their customizable
chemistry and properties. Synthetic hydrogels can be manufactured with various
molecular weights, chain linkages, and solidification methods which can factor into the
material mechanical properties and formation methods. [20] Examples of such material
include, PEO, PEG, PVA, and PLA.
2.1.2 Natural hydrogels
Natural hydrogels are polymers that are made up of components that are either a
part of or have molecular properties similar to that of natural ECM. These materials
include but are not limited to collagen, HA, alginate, and chitosan.
a

Sodium Alginate
Alginate is non-biodegradable, bio-inert, and biocompatible material derived from
brown seaweed and bacteria. It is a hydrophilic, linear polysaccharide of (1–4)-linked ߚD-mannuronic acid (M) and α-L-guluronic acid (G) monomers which are distributed in
either repeating or alternating blocks. [22, 23, 24] Alginate is normally combined with
water or a saline to produce a solution which forms a gel when divalent cations such
as Ca2+, Ba2+, or Sr2+ cooperatively interact with blocks of G monomers to form ionic
bridges between different polymer chains. [22] Following cross linkage, Alginate
undergoes a slow, uncontrolled dissolution with mass loss by ion exchange of calcium
resulting in the dissociation of individual chains and loss of mechanical integrity.
A solution to this can greatly enhance cell viability and hydrogel life.[25] The most
commonly used divalent cation with alginate is Ca2+ , normally used in the form of
Calcium Chloride. Alginate has been proven to be a compatible material with a variety of
uses including drug delivery, cell encapsulation, and in vivo which encourages its use in
tissue engineering.
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Figure
F
2.1: Sttructure of naturally
n
deriived alginatee polymer. ((Drury et al. 2003). Reprrinted
from Biomaterials, Vol 24, Jeeanie L. Druury, David J. Mooney, Paage 4340.

2.2

Additio
on of Carbon Nanotubees
One addition
a
to th
he current alg
ginate hydroogel composition is to addd carbon
hich not only
y have been shown to im
mprove mechhanical propperties, but also
nanotubes, wh
n cell viabilitty. Carbon naanotubes aree sheets of ggraphite rolleed into
have aided in
ylindrical sh
haped tubes. Carbon nano
otubes (CNT
T) are highlyy porous as w
well as
cy
liightweight which
w
provid
des a similariity to naturallly occurringg collagen fiibers of the
ex
xtracellular matrix.
m
Thiss similarity along
a
with thhe size of thee carbon nannotubes allow
ws
th
he ability to greatly influ
uence cell ad
dhesion, prolliferation, annd differentiaation. [26]
Carbon
C
nanottubes can be divided into
o two categoories based ooff of the diaameter size,
siingle walled
d carbon nano
otubes (SWC
CNT) and m
multiple walleed carbon naanotubes
(M
MWCNT). Single
S
walled
d tubes havee a diameter between 0.88 and 2 nanoometers, whille
multiple
m
walled tubes sho
ow a diameteer between 2 and 100 naanometers. [227,28] The
fllexible arran
ngement of th
he carbon ato
oms within tthe tubes givves them greeat mechaniccal
sttrength with a Young’s modulus
m
of 0.27
0 - 1.34 T
TPa and a tennsile strengtth between 11 200 GPa.[29,30] The inco
orporation of carbon nannotubes into a polystyrenne polymer
sh
howed a 36-42% elastic modulus inccrease and a 25% tensilee strength inccrease. [31] A
co
omposite of single walleed carbon naanotubes andd poly-L-lacttide (PLLA) showed a 12%
in
ncrease in ten
nsile strengtth and a redu
uced rate of ddegradation.. [32] Increaases in the tensile
sttrength, redu
uced rate of degradation,
d
, and elastic modulus, am
mong other sstructural
modifications
m
s, are beneficcial when deeveloping strructural tissuues and orgaans such as bbone,
ass a hydrogell scaffolds neeeds to degraade at a rate that will alsso support ceell growth annd
fo
ormation of tissue.
t
[33,34,35] A stud
dy performedd showed thhat the formaation of
hy
ydroxyapatitte crystals, the
t largest mineral
m
compponent of nattural bone, oon SWCNTs and
MWCNTs
M
weere almost id
dentical to osteoblasts cuultured on w
woven bone. Most
in
nterestingly, cells grown
n on SWCNT
Ts, which aree similar in ssize to the trriple helix
co
ollagen fiberrs of natural bone, had diameters
d
mi rroring thosee from naturral osteoblasst
siize. [36] SW
WCNTs have various usess in many tisssue engineeering with reesearch on thhem
taaking place in
i mesenchy
ymal stem ceells and neurral tissue enggineering. SW
WCNTs aliggned
on
n glass substtrates, by centrifugal forrces, comparred to random
mly orientedd SWCNTs
sh
howed a 120
0% increase in mesenchy
ymal stem ceells (MSCs) proliferationn.[37] Neuroonal
ceells grown on
o SWCNT multilayer
m
films showedd stimulated nnerve repair. [38] In dosses of
0.1 and 1µg/m
ml, surface markers
m
and viability of hhuman adipoose stem cellls showed
in
ncreases com
mpared to 10
0, 20, 50, and
d 100 µg/ml after a 7 dayy period. [399, 40]
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With the incorporation of carbon nanotubes into alginate hydrogels, cell viability
and proliferation could be increased and the mechanical structure of these constructs
could be greatly extended and potentially strengthened. This concept should be further
explored as a method for newly printed tissue constructs.
2.2.1 Carbon Nanotube Functionalization
Carbon nanotubes are naturally chemically inert and dispense unevenly in various
polymers. In order to improve biocompatibility and increase the ability to disperse
evenly, functionalization is required in order to incorporate carbon nanotubes into
polymers. [41] Functionalization normally involves the addition of carboxyl or alcohol
groups to the ends of the nanotubes. The bonds formed between the carbon nanotubes
and functional groups are useful in tissue engineering because they are weak enough to
allow various reactions to take place within the biochemical environment, but not too
weak to prevent rapid chemical decay.[42,43] Similar to size, functional groups can have
an effect on cell growth and differentiation. Charged carboxyl groups have shown
increased chondrocyte growth and ECM protein expression. [44] Recent results also have
shown that when functionalizing carbon nanotubes with nitric and sulphuric acids,
functionalization periods of 5 hours compared to .5 hours, increase cell viability. [45]
2.3

Perfluorocarbons
Perfluorocarbons (PFCs) are nonaqueous, cytocompatible, and highly oxygenated
fluids. These hydrocarbons have fluorine substituted in place of most or all hydrogen
atoms, an increased molecular mass, and also specific gravities twice that of water. [46]
Due to the carbon to fluorine bond strength, 487 kJ mol -1, PFCs have noteworthy
chemical and thermal stability, great spatial arrangement, and the ability to dissolve large
quantities of respiratory gases [46]. These solutions have been previously used in
research by Clark and Gollan to test and confirm the survival of small mice fully
submerged in fluorobutyltetrahydrofuran. [46] More recently, research has shown that the
incorporation of these solutions with bioreactors and cell cultures resulted in higher cell
proliferation and cell bioproduct assembly. Various studies using PFC emulsions have
also been conducted for use in preserving human and animal organs before
transplantation. [47, 48]
2.3.1 Addition of Perfluorotributylamine
Perfluorotributylamine (PFTBA) is a type of perfluorocarbon useful with cell and
organ printing due to its inert properties. Perfluorotributylamine has a density of 1.88 g
cm-3, approximately twice the density of water. [49] One of the ideal benefits of
Perfluorotributylamine is that is hydrophobic, which makes it non-miscible leading to
aided mechanical support of printed scaffolds during the three dimensional fabrication
process. Campos et al previously conducted study where stem cell laden agarose
hydrogel scaffolds were printed a Perfluorotributylamine solution. Results showed
excellent improvement in compressive strength, excellent cell viability after 24 hours and
21 days, and increased cell proliferation using stem cells.
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Studies have also demonstrated the use of a PFTBA emulsion, composed of
PFTBA, lecithin, and Phosphate Buffered Saline, increasing oxygen levels within cellular
scaffolds which in turn increase gene expression, cell viability, nerve cell regeneration,
osteogenic differentiation, and bone formation in vivo. [50, 51, 52]
2.4

Future Work
From this review, alginate hydrogel, carbon nanotubes, and PFTBA, all
commonly used in tissue engineering were presented and reviewed. During this process
of examining the many benefits in cell viability and mechanical integrity of these
materials, more research will need to be done to show appropriate configurations and
concentrations of these materials in vitro and in vivo. More extensive lab trials and
animal trials, which will eventually lead to human trials, will need to be done to provide
the date for clinical use.
2.5

Conclusion
The use of alginate hydrogels, carbon nanotubes, and PFTBA, have had notable
occurrences in laboratory use and all have a potential to be further developed for clinical
use in the field of tissue engineered scaffolds. As the need for organ transplants is
increased, the need for alternatives to shortages will continue to rise. Due to the
revolutionary advancements in technology and medicine, there has never been a better
time to continually improve the current knowledge of three dimensionally printed
biological scaffolds. This search for improvement has led to many additives being
experimented with to research if they are able to improve the biological properties of
current hydrogel solutions. These additions to current hydrogel configurations have led to
many developments in aiding three dimensionally printed organ developments, improved
mechanical strength of scaffold models, improved cellular viability and proliferation, and
increased knowledge of tissue engineering. The additives reviewed here have led to
bettering the current understanding of three dimensional scaffolds and additives for tissue
engineering experiments. With further research on the combinations of these materials in
vitro, in vivo, and clinically, much advancement within the field are on the horizon.
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3. IN VITRO EVALUATION OF THREE DIMENSIONALLY PRINTED
PERFLUOROTRIBUTYLAMINE AND CARBON NANOTUBE ENRICHED
ALGINATE SCAFFOLD
3.1

Project Purpose
Due to the large number of organ transplant surgeries occurring each year and
with these procedures projected to increase, there is a need to discover a more effective
alternative to organ transplantation. The idea of customizable, patient exact organ
production is a novel concept currently being worked towards through three dimensional
printing, hydrogels, and human cells and their production to form tissue engineered
scaffolds. There is a need for researchers to become more efficient and gain better control
over the production process, especially regarding cellular viability and mechanical
stability. Current research has shown that these scaffolds lack in mechanical integrity and
life of implanted cells. Poor mechanical integrity can result in poor gas exchange and can
even play a factor in reduced viability of implanted cells. This study explored several
compositions of single walled carbon nanotubes and a emulsion made with
perfluorocarbon, phosphate buffered saline and gelatin from bovine skin. The 5% PFTBA
emulsion + 1 µg/ml SWCNT + alginate, provided the best cell viability results; Picogreen
fluorescence of 8532, excellent viability in live/dead stain, and sufficient morphological
features while the control scaffold, containing alginate only, provided the best
mechanical properties. This composition may have application as an improvement with
hydrogels and could be further explored.
3.2

Materials and Methods
Sodium Alginate and Calcium Chloride (Sigma Aldrich, U.K.) were treated with
ultraviolet (UV) light for sterilization three times for a 30-minute cycle each time. UVsterilized sodium alginate was dissolved in sterile Phosphate Buffer Saline (PBS) to make
2% (w/v) solutions. Similarly, the crosslinking solution was prepared by dissolving UVsterilized Calcium Chloride particles in sterile Dulbecco’s Modified Eagle Medium
(DMEM) supplemented with 10% fetal bovine serum (FBS) and 1% triple antibiotic
achieving 4% (w/v). Solutions were mixed with a magnetic stirrer at room temperature
until homogeneity was reached. To eliminate any remaining contaminant, both solutions
were passed through a filter with a pore size of 0.22 µm.
3.2.1 Carbon nanotube Functionalization
Single Walled Carbon Nanotubes were obtained in powder form from US
Research Nanomaterials, Inc. (Stock#: US 4110) with average diameter 1.1 nm and a
length of 5- 30 µm. The purity of SWCNTs used was >90%. 30 mg of pure SWCNTs
was dispersed in 60 mL of 1:3 mixture of 98% nitric acid (HNO3) and 70% sulfuric acid
(H2SO4) in a round bottom flask equipped with a condenser and refluxed for 180
minutes at 120°C while stirring at a rate of 500 rpm as shown in figure 3.1. [45]
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nctionalizatio
on set up inccluding wateer bath, conddenser, flaskk, oil
Figure 3.1: SWCNT fun
bath,
b
hot platte, balloon, aand thermom
meter.
CNTs were centrifuged for 10 minuutes at 2400 × g and sonicated
Neext, the acid--treated SWC
forr 1 hour with
h water in so
onicator exch
hanged everyy 20 mins too prevent oveerheating. The
SW
WCNTs were washed ex
xtensively in 1200 ml of deionized w
water until a constant pH
H
vaalue in the raange of 5–6 was
w attained and was colllected on a .22 µm filtering membraane.
Th
he SWCNTs were then washed
w
with PBS to achiieve a pH off 7. Finally, tthe SWCNT
Ts
weere washed off
o of the meembrane into
o 6, 50 ml ceentrifuge tubbes, frozen using liquid
nittrogen, and dried
d
inside a vacuum ch
hamber overr two days att 80 °C. The resulting
fun
nctionalizatiion of the SW
WCNTs wass determinedd by Fourier Transform IInfra-Red (FTIR)
spectroscopy using
u
potassiium bromidee plates. Prevvious researrch has show
wn that succeessful
atttachment of the carboxyll group is ev
vident by a ppeak in the abbsorbance arround betweeen
17
700 cm-1 and
d 1750 cm-1, as shown in figure 3.2, w
which showss the unfuncctionalized siingle
waalled carbon nanotubes and
a figure 3.3 which shoows the functionalized siingle walled
carbon nanotu
ubes.
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Figure
F
3.2: Absorbance
A
vs
v Wavenum
mber display of unfunctioonalized singgle walled caarbon
nanotubess.

Figure 3.3: Absorbance
A
vs Wavenum
mber displayy of functionnalized singlle walled carrbon
nanotubes. Inverse peak
k around 171
17 cm-1 conffirms successful attachm
ment of carbooxyl
groups to sing
gle walled c arbon nanotu
tubes.
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3.2.2 Dispersion of Carbon Nanotubes
The preparation of carbon nanotubes in Dulbecco’s Modified Eagle Medium
(DMEM) supplemented with 10% fetal bovine serum (FBS) and 1% triple antibiotic used
a sonication/centrifugation protocol described by Chin et. al. [53] Briefly, 1 mg of
functionalized SWCNT powder was dispensed into an Eppendorf tube containing 1 ml of
DMEM/FBS, vortexed for 1 min and sonicated for 10 min at 0 degrees Celsius. The
resulting suspension was centrifuged in an Eppendorf tube for 2 minutes at 16,000 g. The
supernatant was carefully recovered to produce a DMEM-SWCNT dispersion.
3.2.3 Perfluorotributylamine Emulsion Preparation
A PFTBA emulsion was prepared in the following manner. 95 mg of gelatin from
bovine skin and 400 µL PFTBA was added to 600 µL of phosphate buffered solution.[50,
51, 52] The solution was sonicated at 4 °C twelve times for 15 seconds with a 1 minute
interval between each sonication.
The mixture was then reheated in a water bath of 37 °C and vortexed before
usage. The PFTBA emulsion was sterilized by filtering through a .22 µm membrane filter
and treated with UV light for sterilization three times for a 30-minute cycle each time.
3.2.4 Cell Culture
NIH 3T3 mouse fibroblast from passages 14 to 27 were cultured in Dulbecco’s
Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and
1% triple antibiotic in 25 cm2 tissue culture flasks. All cells were incubated at 37°C and
5% CO2. The media was changed in each flask every 3 days and passaged at 80%
confluence.
3.2.5 Scaffold Fabrication
Mouse fibroblast cells were resuspended at 250,000 cells/ml in 2% sodium
alginate by vortexing for 10-20 seconds. Alginate with Mouse fibroblast cells was taken
into 20ml syringes and passed through medical tubing to a 20 gauge needle tip. 4%
Calcium chloride was also taken into a 20 ml syringe passed through medical tubing to a
22 gauge needle. Both of which were attached to a custom 3D printed face of the
Reprappro Mendel 3D printer. The Alginate solution syringe was controlled by the
extruder motor of the printer which was attached to a syringe extruder. This allowed for
the control of the printing material directly from the printer. The calcium chloride solution
was extruded at an angle so as to drip down the needle of the alginate. The extrusion was
controlled by an external syringe pump that was set to 70 ml/h. A 5 mm tall, 4 mm
diameter cylinder structure was created using a SolidWorks which was then converted to
g- code through the software Slic3r. The g-code was then loaded to Pronterface. Scaffolds
were printed in various configurations, incubated for 7 days with media exchanged 3 days
after print, and tested. The control scaffold contained no carbon nanotubes and no PFTBA
emulsion. The remaining 3 scaffolds were printed with increasing amounts of carbon
nanotubes starting at 0 µg/ml to .1 µg/ml and lastly 1 µg/ml with a 5% v/v addition of
PFTBA emulsion. Scaffolds were printed in triplicates for each experiment.
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Table 1: Scaffold Coonfigurationss
Co
ontrol Scaffo
fold

Scaffoold 1

Scafffold 2

Scaaffold 3

Carbon
C
nano
otubes

0 µg/ml

0 µgg/ml

.1 µ
µg/ml

1 µg/ml

PFTBA
P
Emu
ulsion

0%

5%

5%

5%

Figure
F
3.4: Scaffold
S
fabrrication proccess illustratting the extruusion of the various alginate
hydrogel configuration
c
ns and the caalcium chlorride angled ddrip method to solidify thhe
scaaffold structtures.
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3.3

Cell Viability Studies

3.3.1 Live/Dead Assay
The 3D cell laden hydrogels were incubated under controlled conditions for 7
days. The live/dead assay was created using 20µL of EthD-1, 10ml D-PBS, and 5µl
calcein AU. The prints were moved to a 48 well plate and covered with solution. Images
were taken using a lumar-stereo microscope.
3.3.2 Picogreen
The printed structures were incubated and put on a rocker with proteinase K at
56˚C overnight. 50µl of the solution with 50µl of Picogreen dye were migrated to a 96
well plate. The samples were exposed to 480nm light, and the total DNA concentration
was compared to each other.
3.4

Cell Morphology Studies

3.4.1 F.Actin Stain
The printed structures were rinsed with PBS, fixed with 4% paraformaldehyde for
20 minutes, and rinsed again with PBS. Next the scaffolds were permeabilized with 0.1%
triton x-100 for 10 minutes and lastly stained with ActinGreen 488 reagent for 30 mins.
Following the process, the stain was removed; the scaffolds were rinsed with PBS and
imaged using a confocal microscope.
3.5

Mechanical Analysis
Compression testing was performed at room temperature on the structures each
being 8mm diameter and 10mm in height. This was done using a hydraulic universal
testing machine (MODEL) using an extension rate of 1 mm min-1.
3.6

Statistical Analysis
All results were expressed as a mean ± percent error.

3.7

Results

3.7.1 Live/Dead Stain
To analyze the 3D scaffolds with respect to cell viability. Mouse fibroblast cells
were seeded at a density of 250,000 cells per milliliter. The cell images for the mouse
fibroblast cells revealed excellent cell viability 7 days after the printing process and
incubation period. As shown if figures 3.5, 3.6, 3.7, and 3.8
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Control:

Figure 3.5: Live/dead Control
C
staining showingg viable 3T3, 7 days afteer being printted.

5% PFT
TBA Emulssion:

Figure 3.6: Live/dead 5%
5 PFTBA Emulsion
E
staaining showiing viable 3T
T3, 7 days after
being printted.
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.1 µg/m
ml Carbon Nanotubes;
N
5%
5 PFTBA
A Emulsion:

Figure 3.7
7: Live/dead
d .1 µg/ml Carbon Nanottubes; 5% PF
FTBA Emullsion staininng
show
wing viable 3T3, 7 days after being printed.
1 µg/mll Carbon Na
anotubes; 5% PFTBA Emulsion:

Figure 3.8: Live/dead
d 1 µg/ml Caarbon Nanottubes; 5% PF
FTBA Emullsion stainingg
show
wing viable 3T3, 7 days after being printed.
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3.7.2 Picogreen
For samples undergoing fluorescence analysis, a cell concentration of 250,000
cells per milliliter was used. The numerical value of the fluorescence tends to directly
correlate to the numerical value of the actual number of cells counted within each
scaffold structure. The Picogreen begins with an average of fluorescence of 2611 and
increases to 4965, 5370, and 8532, for the controls, 5% PFTBA emulsion scaffolds, .1
µg/ml, and 1 µg/ml scaffolds, respectively, as shown if figure 3.9. The fluorescence
activity shown in the chart below, of the mouse fibroblast cells, tends to increase from the
control scaffolds to those with no carbon nanotubes and a 5% pftba emulsion, to those
with increasing amounts of carbon nanotubes, .1 µg/ml and 1 µg/ml, with a 5% pftba
emulsion. Statistically speaking, there was a 90.157% increase between the control
scaffolds and the scaffolds containing a 5% pftba emulsion. There was an 8.157%
increase between the scaffolds containing a 5% pftba emulsion and those containing a 5%
pftba emulsion and .1 µg/ml carbon nanotube concentrations. Lastly, there was 58.883%
increase between the scaffolds containing a 5% pftba emulsion and .1 µg/ml carbon
nanotube concentrations and those containing a 5% pftba emulsion and 1 µg/ml carbon
nanotube concentrations.

Picogreen
12000

10000

Fluorescence

8000

6000

4000

2000

0

Series1

Control

5% PFTBA
Emulsion

.1 µg/ml + 5%
PFTBA Emulsion

1 µg/ml + 5%
PFTBA Emulsion

2611

4965

5370

8532

Figure 3.9: Fluorescence of 3T3 laden hydrogels after 7 days.
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3.7.3 F.Actin
n Stain
To analy
yze the 3D scaffolds
s
witth respect to cell viabilitty. Mouse fibbroblast cellls
weere seeded att a density of 250,000 ceells per milliiliter. The ceell images foor the mouse
fib
broblast cellss revealed ceell morpholo
ogy unique too those comm
mmonly foundd to normal
mo
ouse fibroblaast cells for all of the varrious scaffolld configuraations. As shown in figurres
3.1
10, 3.11, 3.12, and 3.13.

Control:
C

Figure
F
3.10: F.Actin
F
Con
ntrol staining
g showing ceell morpholoogy of 3T3, 7 days after bbeing
printed.

5% PFT
TBA Emulsiion:

Figure
F
3.11: F.Actin 5%
% PFTBA Em
mulsion stainning showingg cell morphhology of 3T
T3, 7
dayss after being printed.

17

.1 µg/mll Carbon Na
anotubes; 5%
% PFTBA E
Emulsion:

Figure
F
3.12: F.Actin .1µg
g/ml Carbon
n Nanotubes;; 5% PFTBA
A Emulsion sstaining show
wing
cell morphology
m
of
o 3T3, 7 dayys after beinng printed.

1 µg/ml Carbon Nanotubes; 5%
% PFTBA E
Emulsion:

Figure
F
3.13: F.Actin 1µg
g/ml Carbon Nanotubes; 5% PFTBA
A Emulsion sstaining show
wing
cell morphology
m
of
o 3T3, 7 dayys after beinng printed.

3.7.4

Mech
hanical Anallysis

The priinted scaffollds were seeded with cellls at a densiity of 250,0000 cells per
miilliliter. Threee scaffolds of each typee were evaluaated 7 days aafter print. T
The three
specimens werre tested at a rate of 1 mm per minutte using a 2 kkN load celll.
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The tests were performed at room temperature. The mechanical tests revealed a
vast difference in the stress, strain, and compressive strength between the control and
combination scaffolds. The Young’s Modulus begins with an average of 12,850 kPa and
decreases to 2639, 2382, and 1609 kPa, for the controls, 5% PFTBA emulsion scaffolds,
.1 µg/ml, and 1 µg/ml scaffolds, respectively, as shown in figure 3.14.

Young's Modulus
18000
16000
14000
12000
kPa

10000
8000
6000
4000
2000
0
-2000

Series1

Control

5% PFTBA
Emulsion

.1 ug/ml + 5%
PFTBA Emulsion

1 ug/ml + 5%
PFTBA Emulsion

12849.60667

2639.333333

2382.076667

1608.616667

Figure 3.14: Young’s Modulus of 3T3 laden hydrogels after 7 days. The control scaffold
had significantly higher results than the remaining scaffolds. The remaining scaffolds
decreased in results, with increasing concentration of SWCNTs.
Statistically speaking, there was a 79.459% decrease between the control scaffolds
and the scaffolds containing a 5% pftba emulsion. There was a 9.747% decrease between
the scaffolds containing a 5% pftba emulsion and those containing a 5% pftba emulsion
and .1 µg/ml carbon nanotube concentrations. Lastly, there was 32.469% decrease
between the scaffolds containing a 5% pftba emulsion and .1 µg/ml carbon nanotube
concentrations and those containing a 5% pftba emulsion and 1 µg/ml carbon nanotube
concentrations. The Compressive Stress at Tensile Strength begins with an average of 983
kPa and decreases to 302, 274, and 246 kPa, for the controls, 5% PFTBA emulsion
scaffolds, .1 µg/ml and 1 µg/ml scaffolds, respectively, as shown if figure 3.15.
Statistically speaking, there was a 69.313% decrease between the control scaffolds and the
scaffolds containing a 5% pftba emulsion. There was a 9.102% decrease between the
scaffolds containing a 5% pftba emulsion and those containing a 5% pftba emulsion and .1
µg/ml carbon nanotube concentrations.
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Lastly, there was 10.462% decrease between the scaffolds containing a 5% pftba
emulsion and .1 µg/ml carbon nanotube concentrations and those containing a 5% pftba
emulsion and 1 µg/ml carbon nanotube concentrations. These results are most likely due
to the incorporation of the PFTBA emulsion.

Compressive Stress at Tensile Strength
1400
1200

kPa

1000
800
600
400
200
0

Series1

Control

5% PFTBA
Emulsion

.1 ug/ml + 5%
PFTBA Emulsion

1 ug/ml + 5%
PFTBA Emulsion

983.33

301.75

274.2833333

245.5866667

Figure 3.15: Compressive Stress of 3T3 laden hydrogels after 7 days. The control
scaffold had significantly higher results than the remaining scaffolds. The remaining
scaffolds decreased in results, with increasing concentration of SWCNTs.

3.8

Discussion
Three dimensional cell laden scaffolds are produced through the combination of
three dimensional bio-plotters and printers, computer assisted design software, hydrogels,
and various cell types. Cells are infused within hydrogels and are then extruded through
tubing by the printer to produce computer designed structures. These structures are
intended to be identical to their computer and organ models, however lack the necessary
mechanical and chemical features to encourage cellular life once printed. Success with
cellular scaffolds is due to proper selection of hydrogels and key additives in various
concentrations. Single walled carbon nanotubes were chosen due to their ability to
increase mechanical features in three dimensional scaffolds and other biomaterials. The
incorporation of perfluorotributylamine was also used to increase cell viability due to
various studies showing its success in tissue formation.
This study was conducted to determine the scaffold’s structure as a function of
alginate hydrogel with an added constant perfluorotributylamine concentration with
increasing amounts of single walled carbon nanotubes.
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Four scaffolds concentrations were produced, a alginate control with no single
walled carbon nanotubes and no perfluorotributylamine, alginate with 5% by weight
perfluorotributylamine, alginate with 5% by weight perfluorotributylamine and .1 µg/ml
single walled carbon nanotubes, and alginate with 5% by weight perfluorotributylamine
and 1 µg/ml single walled carbon nanotubes.
Working with the control and the three modified scaffolds, the results display
high cell viability. Results show increased cell viability with the addition of the
perfluorotributylamine emulsion and increase with increasing amounts of single walled
carbon nanotubes. The increased cell viability in the scaffolds containing the
perfluorotributylamine is believed to have occurred due to the increased oxygen content
that is normally associated with the addition of perfluorotributylamine and also due to the
imitated extracellular matrix produced by the single walled carbon nanotubes.
The mechanical properties are shown to decrease with the addition of
perfluorotributylamine and continue to decrease as the carbon nanotube concentration is
increased, correlating indirectly with the hypothesis. The poor mechanical properties in
the alginate with 5% by weight perfluorotributylamine, alginate with 5% by weight
perfluorotributylamine and .1 µg/ml single walled carbon nanotubes, and alginate with
5% by weight perfluorotributylamine and 1 µg/ml single walled carbon nanotubes
scaffolds are hypothesized to be due to the addition of perfluorotributylamine. In future
studies, adjusting the amount of perfluorotributylamine can potentially increase
mechanical properties.
3.9

Conclusion
The utilization of three dimensional bio plotting provides an opportunity for
researchers and engineers to create an alternative method to donor exact organ
transplantation. This study explored the effect of different concentrations of single walled
carbon nanotubes added in increasing amounts to a 5% perfluorotributylamine emulsion
and concluded that the 5% by weight perfluorotributylamine emulsion and 1 µg/ml single
walled carbon nanotube scaffold displayed the highest cell viability compared to the
control, alginate with 5% by weight perfluorotributylamine, alginate with 5% by weight
perfluorotributylamine and .1 µg/ml single walled carbon nanotube scaffolds. The control
scaffold with a 0 concentration of both single walled carbon nanotubes and
perfluorotributylamine emulsion displayed the optimal mechanical strength compared to
the 5% by weight perfluorotributylamine, alginate with 5% by weight
perfluorotributylamine and .1 µg/ml single walled carbon nanotubes, and alginate with
5% by weight perfluorotributylamine and 1 µg/ml single walled carbon nanotubes
scaffolds. Based on these results further studies may prove beneficial to exploring a better
combination of the proposed components to increase cell viability while also increasing
or maintaining mechanical properties.
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4. SUMMARY, CONCLUSIONS, AND RECOMMENDATIONS
4.1

Summary
Three dimensionally printed constructs are a stepping stone to the application of
fully printed donor identical organs and tissues. The use of alginate hydrogels crosslinked with calcium chloride to form three dimensional shapes has been widely
researched in literature, with various additives and configurations. Within this study of
the additive benefits of carbon nanotubes and perfluorotributylamine into an alginate
hydrogel structure formed via a three dimensional bioplotter, various combinations were
produced with a potential to increase mechanical stability and cellular viability. This
study is beneficial to the growing need for donor substitutions and patient identical
constructs which will be immune compatible.
These scaffold configurations are similar to those widely used in various research
programs where alginate is the base hydrogel.
To study the potential of this theory an in vitro study was conducted to test the
cytocompatibility, mechanical properties, and the morphological effects on cells as a
function of the configuration of a perfluorotributylamine addition to increasing
concentrations of carbon nanotubes within alginate. The alginate only, 5%
perfluorotributylamine + alginate, 5% perfluorotributylamine + .1 µg/ml carbon nanotube
+ alginate, and 5% perfluorotributylamine + 1 µg/ml carbon nanotube + alginate
scaffolds underwent an live/dead assay, Picogreen assay, f-actin stain, and compression
testing.
4.2

Conclusions
The results of this study indicate that the configuration of 5%
perfluorotributylamine + 1 µg/ml carbon nanotube + alginate, provided the best cell
viability results; Picogreen fluorescence of 8532, excellent viability in live/dead stain,
and excellent morphological features. The control scaffold, containing alginate only,
provided the best mechanical integrity compared to the other configurations. This
provides more insight to the proper configuration between perfluorotributylamine and
carbon nanotubes within an alginate scaffold to reach a non-toxic, mechanically stable
structure. The Picogreen fluorescence of the scaffolds increased with increasing carbon
nanotube concentration while mechanical properties decreased with increasing carbon
nanotube concentration. Further research into effect on the morphological structure could
be done.
4.3 Recommendations
1. Testing various other hydrogels and hydrogel configurations instead of alginate and
calcium chloride as a cross linking solution with the perfluorotributylamine emulsion and
single walled carbon nanotube configurations used in this study. This may lead to
increased mechanical properties.
2. Testing the incorporation of various other types of perfluorocarbons instead of
perfluorotributylamine to research their effect on the used configurations.
3. Testing the use of strictly perfluorotributylamine emulsion without any single walled
carbon nanotubes.
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4. Varying the amount of perfluorotributylamine emulsion and researching its effect on the
previously used single walled carbon nanotube concentrations.
5. Tensile and fatigue testing could be done to better understand the mechanical limitations
of the current models.
6. An in vivo study within an animal model could be conducted to get a real life application
of the effects of mechanical strength and compatibility.
7. A study on the incorporation of adipose derived stem cells and their ability to
differentiate into various cell lines within the various scaffold configurations.
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